Plasbumin United States
United States

 Advanced Search

Print this Page
The Albumin Safety Advantage. Low Aluminum

Who needs low aluminum albumin?

Many patients may be at high risk for aluminum toxicity from parenteral treatments.1 These individuals include1-4:

Newborns
Premature infants receiving IV therapy
The elderly
Dialysis patients and others with impaired renal function
Patients receiving total parenteral nutrition
Burn patients

Now there's one albumin for these patients: Albumin with reduced aluminum content from Talecris Biotherapeutics.

References

1.   Koo WW, Kaplan LA. Aluminum and bone disorders: with specific reference to aluminum contamination of infant nutrients. J Am Coll Nutr. 1988;7(3):199-214.
2.   Milliner DS, Shinaberger JH, Shuman P, Coburn JW. Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. N Engl J Med. 1985;312(3):165-167.
3.   Klein GL, Herndon DN, Rutan TC, Barnett JR, Miller NL, Alfrey AC. Risk of aluminum accumulation in patients with burns and ways to reduce it. J Burn Care Rehabil. 1994;15(4):354-358.
4.   Berend K, van der Voet G, Boer WH. Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe. Kidney Int. 2001;59(2):746-753.
Plasbumin® Home  |   Healthcare Professionals  |   Excipient Customers  |   Patients
Important Safety Information  |   Prescribing Information  |   Site Map  |   Glossary



Talecris Biotherapeutics
Contact Talecris    General Conditions of Use    Privacy Statement   
This site is intended for US residents only. Non-US residents can go to www.Talecris.com.
© 2007 Talecris Biotherapeutics


 

 

 

 

 

 

Update Flash